XFOR financials

X4 Pharmaceuticals (XFOR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

XFOR income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$35.11M$29.36M-$86.88M-$79.20M-1.87
2024$2.56M$1.76M-$36.40M-$37.45M-5.59
2023$0.00$0.00-$107.52M-$101.17M-17.07
2022$0.00$0.00-$87.57M-$96.41M-45.60
2021$0.00–-$85.11M-$102.64M-119.70
2020$3.00M–-$59.87M-$62.13M-92.70